BRPI9907025B8 - polissacarídeos sintéticos e uso dos mesmos - Google Patents

polissacarídeos sintéticos e uso dos mesmos

Info

Publication number
BRPI9907025B8
BRPI9907025B8 BRPI9907025A BR9907025A BRPI9907025B8 BR PI9907025 B8 BRPI9907025 B8 BR PI9907025B8 BR PI9907025 A BRPI9907025 A BR PI9907025A BR 9907025 A BR9907025 A BR 9907025A BR PI9907025 B8 BRPI9907025 B8 BR PI9907025B8
Authority
BR
Brazil
Prior art keywords
synthetic polysaccharides
polysaccharides
synthetic
formulas
diseases
Prior art date
Application number
BRPI9907025A
Other languages
English (en)
Portuguese (pt)
Other versions
BR9907025A (pt
BR9907025B1 (pt
Inventor
Constant Van Boeckel
Cornelia Tromp
Jean-Marc Herbert
Johannes Basten
Maurice Petitou
Philippe Duchaussoy
Pierre-Alexandre Driguez
Original Assignee
Akzo Nobel Nv
Sanofi Aventis
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Sanofi Aventis, Sanofi Synthelabo filed Critical Akzo Nobel Nv
Publication of BR9907025A publication Critical patent/BR9907025A/pt
Publication of BR9907025B1 publication Critical patent/BR9907025B1/pt
Publication of BRPI9907025B8 publication Critical patent/BRPI9907025B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
BRPI9907025A 1998-01-19 1999-01-13 polissacarídeos sintéticos e uso dos mesmos BRPI9907025B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9800515A FR2773804B1 (fr) 1998-01-19 1998-01-19 Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
PCT/FR1999/000044 WO1999036443A1 (fr) 1998-01-19 1999-01-13 Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant

Publications (3)

Publication Number Publication Date
BR9907025A BR9907025A (pt) 2000-10-17
BR9907025B1 BR9907025B1 (pt) 2013-12-10
BRPI9907025B8 true BRPI9907025B8 (pt) 2016-09-13

Family

ID=9521914

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9907025A BRPI9907025B8 (pt) 1998-01-19 1999-01-13 polissacarídeos sintéticos e uso dos mesmos

Country Status (41)

Country Link
US (1) US6528497B1 (ja)
EP (1) EP1049721B1 (ja)
JP (1) JP4402835B2 (ja)
KR (1) KR100513196B1 (ja)
CN (1) CN1165550C (ja)
AR (1) AR013019A1 (ja)
AT (1) ATE209219T1 (ja)
AU (1) AU741748B2 (ja)
BR (1) BRPI9907025B8 (ja)
CA (1) CA2317465C (ja)
CO (1) CO4970795A1 (ja)
CZ (1) CZ297815B6 (ja)
DE (1) DE69900718T2 (ja)
DK (1) DK1049721T3 (ja)
DZ (1) DZ2709A1 (ja)
EE (1) EE04157B1 (ja)
EG (1) EG23982A (ja)
ES (1) ES2168000T3 (ja)
FR (1) FR2773804B1 (ja)
GT (1) GT199900003A (ja)
HK (1) HK1030002A1 (ja)
HR (1) HRP20000480B1 (ja)
HU (1) HU228333B1 (ja)
IL (1) IL137241A0 (ja)
MA (1) MA26597A1 (ja)
MY (1) MY119090A (ja)
NO (1) NO329903B1 (ja)
NZ (1) NZ505492A (ja)
PE (1) PE20000269A1 (ja)
PL (1) PL202802B1 (ja)
PT (1) PT1049721E (ja)
RU (1) RU2211224C2 (ja)
SA (1) SA99191113B1 (ja)
SI (1) SI1049721T1 (ja)
SK (1) SK283411B6 (ja)
TR (1) TR200002078T2 (ja)
TW (1) TW548279B (ja)
UA (1) UA60352C2 (ja)
UY (1) UY25356A1 (ja)
WO (1) WO1999036443A1 (ja)
ZA (1) ZA99355B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
FR2874924B1 (fr) * 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
IL188647A0 (en) 2008-01-08 2008-11-03 Orina Gribova Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
US8791064B2 (en) * 2008-04-24 2014-07-29 Technion Research And Development Foundation Ltd. Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds
CA2724910C (en) 2008-05-30 2015-09-01 Momenta Pharmaceuticals, Inc. Saccharide structures and methods of making and using such structures
FR2935386B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine
EP2414371A4 (en) * 2009-03-30 2014-06-25 Univ Georgia HEPARANSULFATSYNTHESE
WO2011004376A1 (en) 2009-07-09 2011-01-13 Oshadi Drug Administration Ltd. Matrix carrier compositions, methods and uses
EP3666786A1 (en) 2009-07-31 2020-06-17 Reliable Biopharmaceutical Corporation Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
FR2949114B1 (fr) 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949115B1 (fr) 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
EP2614089A1 (fr) 2010-09-10 2013-07-17 Sanofi-Aventis Polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree
US9005664B2 (en) 2010-10-17 2015-04-14 Technion Research And Development Foundation Ltd. Denatured lactoglobulin and polyphenol coassemblies
FR2970969B1 (fr) 2011-01-27 2013-10-18 Sanofi Aventis Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260933A (en) * 1993-07-16 1996-07-26 Hercules Inc Cation-complexed polysaccharides; use in foods and pharmaceuticals
FR2749849B1 (fr) * 1996-06-14 1998-09-04 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
CZ427499A3 (cs) * 1998-05-29 2000-05-17 The Procter & Gamble Company Jemné topické antimikrobiální přípravky

Also Published As

Publication number Publication date
TR200002078T2 (tr) 2000-11-21
MY119090A (en) 2005-03-31
CN1165550C (zh) 2004-09-08
GT199900003A (es) 2000-07-07
FR2773804A1 (fr) 1999-07-23
BR9907025A (pt) 2000-10-17
BR9907025B1 (pt) 2013-12-10
EE04157B1 (et) 2003-10-15
AU741748B2 (en) 2001-12-06
AU1974599A (en) 1999-08-02
HUP0102009A3 (en) 2003-07-28
CZ297815B6 (cs) 2007-04-04
CO4970795A1 (es) 2000-11-07
HK1030002A1 (en) 2001-04-20
NO20003662L (no) 2000-09-14
KR100513196B1 (ko) 2005-09-07
DE69900718T2 (de) 2002-08-22
SK283411B6 (sk) 2003-07-01
KR20010034189A (ko) 2001-04-25
HRP20000480B1 (en) 2002-04-30
HRP20000480A2 (en) 2000-12-31
ZA99355B (en) 2000-10-11
SA99191113B1 (ar) 2006-10-11
FR2773804B1 (fr) 2000-02-18
SK10782000A3 (sk) 2001-02-12
EE200000429A1 (et) 2003-06-16
EG23982A (en) 2008-02-27
CA2317465A1 (en) 1999-07-22
HUP0102009A1 (hu) 2001-11-28
CN1288470A (zh) 2001-03-21
AR013019A1 (es) 2000-11-22
JP2002509164A (ja) 2002-03-26
WO1999036443A1 (fr) 1999-07-22
PL202802B1 (pl) 2009-07-31
NZ505492A (en) 2001-12-21
RU2211224C2 (ru) 2003-08-27
NO20003662D0 (no) 2000-07-17
PT1049721E (pt) 2002-05-31
HU228333B1 (en) 2013-03-28
MA26597A1 (fr) 2004-12-20
US6528497B1 (en) 2003-03-04
SI1049721T1 (en) 2002-06-30
UY25356A1 (es) 2000-10-31
EP1049721B1 (fr) 2001-11-21
CA2317465C (en) 2008-05-20
PE20000269A1 (es) 2000-06-15
ES2168000T3 (es) 2002-05-16
TW548279B (en) 2003-08-21
JP4402835B2 (ja) 2010-01-20
EE200000429A (et) 2001-12-17
PL341875A1 (en) 2001-05-07
DK1049721T3 (da) 2002-04-02
CZ20002635A3 (cs) 2000-12-13
ATE209219T1 (de) 2001-12-15
EP1049721A1 (fr) 2000-11-08
DZ2709A1 (fr) 2003-09-01
NO329903B1 (no) 2011-01-24
IL137241A0 (en) 2001-07-24
UA60352C2 (uk) 2003-10-15
DE69900718D1 (de) 2002-02-21

Similar Documents

Publication Publication Date Title
BRPI9907025B8 (pt) polissacarídeos sintéticos e uso dos mesmos
BR0113710A (pt) Compostos, processo para a preparação e utilização dos mesmos, composição farmacêutica, processo para o tratamento e profilaxia de artrite, enfermidades cardiovasculares, diabetes, insuficiência renal, distúrbios alimentares e obesidade
BR9916307A (pt) Derivados quinolina
BR9814118A (pt) Nova composição de matéria
BR9712808A (pt) Indol-3-glioxilamidas n-substituìdas com efeito antiasmático, anti-alérgico e imunossupressor/imunomodulador
BR9807577A (pt) Método para prevenir e retardar o inìcio da doença de alzheimer e sua composição
BR9813811A (pt) "composições farmacêuticas compreendendo micelas que compreendem glicocorticosteróide lipofìlico e apenas um único tensoativo"
BR9913945A (pt) Composição farmacêutica para o tratamento de distúrbios agudos por meio de administração sublingual, e, processo para o tratamento de distúrbios agudos
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
DE3851152D1 (de) Cyclosporin-augenmittel.
ME00520B (me) Levodop/karbidop/entakapon farmaceutski preparat
PT99400A (pt) Processo para a preparacao de derivados de 3-amido- e 3-sulfamido-indolilo e de composicoes farmaceuticas que os contem
BR9712321A (pt) Aminotiofenocarboxamidas
DE3688038T2 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
BR0011831A (pt) Compostos, processo para preparar os mesmos, composições farmacêuticas, e, uso dos compostos
EA199700380A1 (ru) Бициклические ароматические соединения, фармацевтическая и косметическая композиции на их основе и применение косметической композиции
DE68911891D1 (de) Verwendung von Acetyl-L-carnitin zur Behandlung von Katarakt, sowie pharmazeutische Zusammensetzungen für eine derartige Behandlung.
BR9902808A (pt) Compostos, composição farmacêutica, composição cosmética e uso de uma composição cosmética
KR940018087A (ko) 진통제 및 소염제로서의 6-클로로-5-플루오로-3-(2-테노일)-2-옥신돌-ⅰ-카복스아미드
EA199700381A1 (ru) Диароматические соединения пропинила или диенила, промежуточные соединения, фармацевтические и косметические композиции на основе указанных соединений и применение косметических композиций
BR0209206A (pt) Clatrato de hidrato de azitromicina com 1,2-propileno glicol, processo para a sua preparação e composição farmacêutica compreendendo o mesmo
BR0111933A (pt) Uso de ácido pamÈico ou um de seus derivados, ou um de seus análogos, para a preparação de um medicamento para o tratamento de doenças caracterizadas por depósitos de agregados amilõides
HUP9902135A2 (hu) (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
BR0306778A (pt) Derivados de carboxamidina e seu uso no tratamento de doenças vasculares

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SANOFI-SYNTHELABO (FR)

Free format text: TRANSFERIDO DE: AKZO NOBEL N.V.

B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO DE PATENTE DE INVENCAO UMA VEZ O MESMO APRESENTA REIVINDICACOES QUE NAO CUMPREM O REQUISITO DE ATIVIDADE INVENTIVA ( ARTIGOS 8O E ARTIGO 13 DA LEI 9.279/96 ), APRESENTA REIVINDICACOES QUE NAO DEFINEM, DE UM MODO CLARO E PRECISO, A MATERIA OBJETO DE PROTECAO ( ARTIGO 25 DA LEI 9.279/96 ) E O RELATORIO DESCRITIVO NAO DESCREVE, CLARA E SUFICIENTEMENTE O OBJETO, DE MODO A POSSIBILIATR A SUA REPRODUCAO POR UM TECNICO NO ASSUNTO ( ARTIGO 24 DA LEI 9.279/96)

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/12/2013, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REFERENTE AO DESPACHO 16.1 PUBLICADO NA RPI 2240 DE 10.12.2013, QUANTO AO NOME DO INVENTOR

B15K Others concerning applications: alteration of classification

Ipc: C08B 37/00 (2006.01)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2497 DE 13-11-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.